Sort
23,748 grants matching “melanoma”
Molecular Response and Imaging-based Combination Strategies for Optimal PDT
$366,904Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2019 · CA
Molecular interactions and regulatory events of telomere proteins
$366,890Derek James Taylor · Case Western Reserve University · R01 · FY2020 · GM
Evaluation of Novel DExD/H Helicases in Innate Immune Signaling
$366,840Glen N. Barber · University Of Miami School Of Medicine · U01 · FY2012 · AI
Project 2: Dual Targeting of B7-H3 in mCRPC
$366,800Kenneth J. Pienta · Johns Hopkins University · P50 · FY2024 · CA
HIV induced anti-cancer HERV immunity in prostate, breast and colon cancers
$366,779Douglas F Nixon · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · CA
Cancer Biology in the Zebrafish
$366,757Leonard I Zon · Boston Children'S Hospital · R01 · FY2012 · CA
The Significance of MARCO Expression by Tumor-Pulsed Dendritic Cells
$366,750James J Mule · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2007 · CA
Defining critical aspects of environmental ultraviolet exposure in melanogenesis
$366,750Myles G Cockburn · University Of Southern California · R01 · FY2009 · ES
Defining critical aspects of environmental ultraviolet exposure in melanogenesis
$366,750Myles G Cockburn · University Of Southern California · R01 · FY2008 · ES
Autoimmune vitiligo and tolerance in the immune response to a melanoma antigen
$366,746Victor H. Engelhard · University Of Virginia · R01 · FY2010 · AI
(PQD1) Clonal heterogeneity and targeted therapy resistance in melanoma
$366,691Aleksandar None Sekulic · Mayo Clinic Arizona · R01 · FY2015 · CA
Targeting the liver for immunotherapy in pancreatic cancer
$366,641Gregory L Beatty · University Of Pennsylvania · R01 · FY2024 · CA
Project 1: Siglec15 as a new target for lung cancer immunotherapy
$366,580Lieping Chen · Yale University · P50 · FY2024 · CA
Separating autoimmunity and anti-tumor immunity
$366,573Isabelle Caroline Le Poole · Northwestern University At Chicago · R01 · FY2018 · CA
Effects of Radiation on Brain Microvasculature and Cognition
$366,542William Edmund Sonntag · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2007 · NS
Augmenting T cell activity to weak tumor antigens and reversing myeloid cell-mediated T cell inhibition
$366,484Eduardo Davila · University Of Colorado Denver · R01 · FY2020 · CA
Augmenting T cell activity to weak tumor antigens and reversing myeloid cell-mediated T cell inhibition
$366,484Eduardo Davila · University Of Colorado Denver · R01 · FY2021 · CA
RNAi manipulations of DC to enhance HIV immunogenicity
$366,438Premlata Shankar · Texas Tech University Health Scis Center · R01 · FY2012 · AI
Therapeutic Targeting of Receptor Tyrosine Kinase Hierarchies in Schwann Cell Neoplasms
$366,394Steven L Carroll · Medical University Of South Carolina · R01 · FY2024 · NS
RNAi manipulations of DC to enhance HIV immunogenicity
$366,363Premlata Shankar · Texas Tech University Health Scis Center · R01 · FY2011 · AI
Targeting the CXCL12/CXCR4 Axis towards the Therapy of Metastatic Cancers
$366,341Rongshi Li · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2013 · CA
Quality and location of presented Ag as determinants of tumor-specific immunity
$366,307Victor H. Engelhard · University Of Virginia · R01 · FY2011 · CA
Quality and location of presented Ag as determinants of tumor-specific immunity
$366,307Victor H. Engelhard · University Of Virginia · R01 · FY2012 · CA
MC1R basis of melanoma-Parkinson's link and neuroprotective potential of MC1R
$366,249Xiqun Chen · Massachusetts General Hospital · R01 · FY2018 · NS
Mutant BRAF as a Therapeutic Target for Melanoma
$366,128Dorothee M Herlyn · Wistar Institute · P01 · FY2012 · CA